Table 3 Relation between metabolic syndrome and grade of steatosis, activity, and fibrosis stage according to SAF score
From: Usefulness of the SAF score to characterize NAFLD/NASH in non-cirrhotic HCV patients
SAF | Grade | Non-MS (n = 45) | MS (n = 25) | P value |
|---|---|---|---|---|
Steatosis | S0 | 25 (35.7%) | 10 (14.3%) | 0.654 |
S1 | 14 (20.0%) | 10 (14.3%) | ||
S2 | 5 (7.1%) | 4 (5.7%) | ||
S3 | 1 (1.4%) | 1 (1.4%) | ||
Activity | A0 | 30 (66.7%) | 15 (60.0%) | 0.791 |
A1 | 4 (8.9%) | 3 (12.0%) | ||
A2 | 10 (22.2%) | 7 (28.0%) | ||
A3 | 1 (2.2%) | 0 (0.0%) | ||
Fibrosis | F0 | 24 (34.3%) | 7 (10.0%) | 0.036* |
F1 | 5 (7.1%) | 9 (12.9%) | ||
F2 | 7 (10.0%) | 4 (5.7%) | ||
F3 | 9 (12.90%) | 5 (7.10%) |